TRANS GENIC INC.
2342・Standard Market・Services
TRANS GENIC INC.2342
TRANS GENIC INC.2342
Reference Indicators
Market Cap
37¥100M
P/E (Forecast)
24.3x
P/B
0.8x
Dividend Yield (Forecast)
0.00%
ROE
-1.7%
EV/EBITDA
12.5x
Financial Summary
Unit: ¥M
| Item | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 |
|---|---|---|---|---|---|
Net Sales | 12,576 | 11,429 | 13,083 | 13,005 | 13,174 |
Cost of Sales | 8,740 | 9,434 | 10,834 | 10,838 | 10,740 |
Gross Profit | 3,835 | 1,994 | 2,249 | 2,166 | 2,433 |
SG&A Expenses | 1,998 | 2,019 | 2,159 | 2,426 | 2,295 |
Operating Income | 1,837 | -25 | 89 | -259 | 137 |
Non-operating Income | 70 | 395 | 88 | 23 | 56 |
Non-operating Expenses | 88 | 170 | 69 | 84 | 76 |
Ordinary Income | 1,819 | 199 | 108 | -319 | 118 |
Extraordinary Income | 1,762 | 41 | 0 | 22 | 174 |
Extraordinary Losses | 813 | 572 | 65 | 378 | 500 |
Pre-tax Income | 2,767 | -331 | 43 | -675 | -207 |
Income Taxes | 907 | 108 | 39 | 414 | -109 |
Net Income | 1,876 | -409 | 4 | -1,089 | -77 |
EBITDA | 2,065 | 158 | 239 | -68 | 293 |
Gross Margin | 30.5% | 17.5% | 17.2% | 16.7% | 18.5% |
Operating Margin | 14.6% | -0.2% | 0.7% | -2.0% | 1.0% |
ROA | 18.0% | -3.8% | 0.0% | -11.4% | -0.8% |
ROE | 32.8% | -6.8% | 0.1% | -23.1% | -1.7% |
Segment Performance
Unit: ¥M
2026
| Segment | Net Sales | Operating Income | Operating Margin |
|---|---|---|---|
| 創薬支援事業 | 2,252 | -164 | -7.3% |
| 投資・コンサルティング事業 | 10,921 | 479 | 4.4% |